TEVA-AZITHROMYCIN
TEVA CANADA LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is TEVA-AZITHROMYCIN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that TEVA-AZITHROMYCIN 250MG has been permanently discontinued (last updated May 28, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is TEVA-AZITHROMYCIN not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PMS-AZITHROMYCIN
PHARMASCIENCE INC
SANDOZ AZITHROMYCIN
SANDOZ CANADA INCORPORATED
RIVA-AZITHROMYCIN
LABORATOIRE RIVA INC.
Other Products
ZITHROMAX CAP 250MG
PFIZER CANADA ULC
ZITHROMAX 600MG
PFIZER CANADA ULC
AZITHROMYCIN
PHARMASCIENCE INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02267845
Strength
250MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Business reasons
Business reasons
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646